Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[61-Year-Old Man with Suddenly Appearing Painful Gluteal Purpura].
Kaddu-Mulindwa D, Bittenbring JT, Müller CSL, Altmeyer S. Kaddu-Mulindwa D, et al. Among authors: bittenbring jt. Dtsch Med Wochenschr. 2018 Aug;143(17):1225-1226. doi: 10.1055/a-0659-3281. Epub 2018 Aug 22. Dtsch Med Wochenschr. 2018. PMID: 30134453 German. No abstract available.
Spontaneous regression of a plasmablastic lymphoma with MYC rearrangement.
Yordanova K, Stilgenbauer S, Bohle RM, Lesan V, Thurner L, Kaddu-Mulindwa D, Bittenbring JT, Scharberger M, Aßmann G, Bewarder M. Yordanova K, et al. Among authors: bittenbring jt. Br J Haematol. 2019 Sep;186(6):e203-e207. doi: 10.1111/bjh.16082. Epub 2019 Jul 1. Br J Haematol. 2019. PMID: 31257571 Free article. No abstract available.
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
Thurner L, Fadle N, Bittenbring JT, Regitz E, Schuck R, Cetin O, Stuhr A, Rixecker T, Murawski N, Poeschel V, Kaddu-Mulindwa D, Preuss KD, Stilgenbauer S, Hermine O, Kluin-Nelemans HC, Hartmann S, Dreyling M, Pott C, Bewarder M, Hoster E. Thurner L, et al. Among authors: bittenbring jt. Blood. 2021 Jun 10;137(23):3251-3258. doi: 10.1182/blood.2020008835. Blood. 2021. PMID: 33513604 Free PMC article. Clinical Trial.
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial.
Krämer I, Stilgenbauer S, Dietrich S, Böttcher S, Zeis M, Stadler M, Bittenbring J, Uharek L, Scheid C, Hegenbart U, Ho A, Hallek M, Kneba M, Schmitz N, Döhner H, Dreger P. Krämer I, et al. Blood. 2017 Sep 21;130(12):1477-1480. doi: 10.1182/blood-2017-04-775841. Epub 2017 Jul 17. Blood. 2017. PMID: 28716861 Free article. Clinical Trial. No abstract available.
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
Buske C, Hoster E, Dreyling M, Eimermacher H, Wandt H, Metzner B, Fuchs R, Bittenbring J, Woermann B, Hohloch K, Hess G, Ludwig WD, Schimke J, Schmitz S, Kneba M, Reiser M, Graeven U, Klapper W, Unterhalt M, Hiddemann W; German Low-Grade Lymphoma Study Group. Buske C, et al. Leukemia. 2009 Jan;23(1):153-61. doi: 10.1038/leu.2008.261. Epub 2008 Sep 25. Leukemia. 2009. PMID: 18818699 Clinical Trial.
66 results